Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropinirole controlled-release for fibromyalgia pain
2004-001680-22Phase 2Completed
- Sponsor
- GSK
- Start
- Sep 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in fibromyalgia (FM) comparing Ropinirole CR 1–24 mg once daily with Placebo (2 arms). Primary endpoint: Change in pain intensity score at Week 12. Started Sep 2004; status: completed.
02
Drugs
ropinirole
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on 2004-001680-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001680-22.